Cargando…

A cost-effectiveness analysis model of Preventicus atrial fibrillation screening from the point of view of statutory health insurance in Germany

BACKGROUND: With atrial fibrillation (AF) the risk of stroke is 4.2-fold increased to a comparable population without AF. This risk decreases by up to 70% if AF is detected early enough and effective stroke preventive measures are taken as recommended by international guidelines. Long-term studies f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Birkemeyer, Ralf, Müller, Alfred, Wahler, Steffen, von der Schulenburg, Johann-Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282133/ https://www.ncbi.nlm.nih.gov/pubmed/32519034 http://dx.doi.org/10.1186/s13561-020-00274-z

Ejemplares similares

Cost-effectiveness of a photopethysmographic procedure for screening for atrial fibrillation in 6 European countries
por: Wahler, Steffen, et al.
Publicado: (2022)

Promoting vaccinations - an analysis of measures taken by German statutory health insurers
por: Damm, Kathrin, et al.
Publicado: (2011)

Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system
por: Kuhlmann, Alexander, et al.
Publicado: (2013)

Seroconversion after needlestick injuries – analyses of statutory accident insurance claims in Germany
por: Dulon, Madeleine, et al.
Publicado: (2018)

Adjuvant treatment of high-risk melanoma – cost-effectiveness analysis of treatment options for BRAF 600 mutated tumors
por: Wahler, Steffen, et al.
Publicado: (2022)

Determining the “Health Benefit Basket” of the Statutory Health Insurance scheme in Germany: Methodologies and criteria
por: Busse, Reinhard, et al.
Publicado: (2005)

Analysis of second opinion programs provided by German statutory and private health insurance – a survey of statutory and private health insurers
por: Könsgen, Nadja, et al.
Publicado: (2021)

Statin‐associated myopathy. Assessment of frequency based on data of all statutory health insurance funds in Germany
por: Ihle, Peter, et al.
Publicado: (2018)

Analyzability of Photoplethysmographic Smartwatch Data by the Preventicus Heartbeats Algorithm During Everyday Life: Feasibility Study
por: Merschel, Steve, et al.
Publicado: (2022)

Patient-rated importance of key information on screening colonoscopy in Germany: a survey of statutory health insurance members
por: Dreier, Maren, et al.
Publicado: (2018)

Risk of psoriatic arthritis depending on age: analysis of data from 65 million people on statutory insurance in Germany
por: Deike, Madeline, et al.
Publicado: (2021)

Epidemiology of Lyme borreliosis based on outpatient claims data of all people with statutory health insurance, Germany, 2019
por: Akmatov, Manas K, et al.
Publicado: (2022)

The Ecological Footprint of COVID-19 mRNA Vaccines: Estimating Greenhouse Gas Emissions in Germany
por: Kurzweil, Peter, et al.
Publicado: (2021)

Continuous Case Management of a German Statutory Health Insurance
por: Hecke, Torsten L., et al.
Publicado: (2005)

Short term cost effectiveness of a regional myocardial infarction network
por: Birkemeyer, Ralf, et al.
Publicado: (2013)

Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in Germany
por: Wahler, S, et al.
Publicado: (2020)

Quality indicators for the evaluation of end-of-life care in Germany – a retrospective cross-sectional analysis of statutory health insurance data
por: van Baal, Katharina, et al.
Publicado: (2020)

The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective
por: Zeidler, Jan, et al.
Publicado: (2012)

Using statutory health insurance data to evaluate non-response in a cross-sectional study on depression among patients with diabetes in Germany
por: Linnenkamp, Ute, et al.
Publicado: (2020)

Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system
por: Höer, Ariane, et al.
Publicado: (2014)

Statutory or Voluntary
por: Neale, A. V.
Publicado: (1956)

Physicians’ Self-Conceptions of Their Expertise in Statutory Health Insurance and Social Security Systems
por: Seger, Wolfgang, et al.
Publicado: (2015)

Burden of HPV related anogenital diseases in young women in Germany – an analysis of German statutory health insurance claims data from 2012 to 2017
por: Reuschenbach, Miriam, et al.
Publicado: (2020)

Cost-related medication nonadherence among over-indebted individuals enrolled in statutory health insurance in Germany: a cross-sectional population study
por: Warth, Jacqueline, et al.
Publicado: (2019)

Epidemiology of pyogenic liver abscesses in Germany: Analysis of incidence, risk factors and mortality rate based on routine data from statutory health insurance
por: Zimmermann, Lisa, et al.
Publicado: (2021)

Evaluation of the statutory surveillance system for invasive MRSA infections in Germany, 2016–2017
por: Schönfeld, Viktoria, et al.
Publicado: (2018)

Options to Extend Medicare’s Trust Fund: Lessons From Japan’s Statutory Health Insurance
por: Maeda, Jared Lane K.
Publicado: (2022)

Prescribing differences in family practice for diabetic patients in Germany according to statutory or private health insurance: the case of DPP-4-inhibitors and GLP-1-agonists
por: Laux, Gunter, et al.
Publicado: (2016)

Statutory health insurance-covered pre-exposure prophylaxis in Germany: changing trends in nationwide tenofovir disoproxil/emtricitabine prescriptions during the COVID-19 pandemic
por: Prins, Henrieke, et al.
Publicado: (2023)

A population-based projection of psoriatic arthritis in Germany until 2050: analysis of national statutory health insurance data of 65 million German population
por: Wang, Jiancong, et al.
Publicado: (2023)

Managers and Statutory Funds
Publicado: (1914)

Syphilis from an Insurance Point of View
por: Maclaren, P. H.
Publicado: (1896)

Cost-savings and potential cost-savings through the distribution of generic antiretroviral drugs within the statutory health insurance market of Germany between January 2017 and June 2019
por: Lottes, Matthäus, et al.
Publicado: (2022)

Social inequalities in the utilization of outpatient psychotherapy: analyses of registry data from German statutory health insurance
por: Epping, Jelena, et al.
Publicado: (2017)

Replacement of endoprosthetic implants within a two years follow-up period: a statutory health insurance routine data analysis
por: Linder, Roland, et al.
Publicado: (2012)

Continuity in palliative care – analysis of intersectoral palliative care based on routine data of a statutory health insurance
por: Rehner, Laura, et al.
Publicado: (2021)

Cardiovascular disease prevalence in type 2 diabetes – an analysis of a large German statutory health insurance database
por: Gabler, Maximilian, et al.
Publicado: (2021)

Trend Analysis by Risk Observation: How the German Statutory Accident Insurance Prepares for the Future in Occupational Safety and Health
por: Hauke, Angelika, et al.
Publicado: (2022)

Agreement between self-reports and statutory health insurance claims data on healthcare utilization in patients with mental disorders
por: Garcia, Tarcyane Barata, et al.
Publicado: (2023)

Digital Health Applications (DiHA): Approaches to develop a reimbursement process for the statutory health insurance in Austria
por: Goetz, Gregor, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ibh9apbgb5nhlq1u1mcri5m0o0